Published in Bioorg Med Chem on July 14, 2010
Macrolones Are a Novel Class of Macrolide Antibiotics Active against Key Resistant Respiratory Pathogens In Vitro and In Vivo. Antimicrob Agents Chemother (2016) 0.75
Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov (2006) 15.21
Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2. Vaccine (2003) 2.00
Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK). Biochem J (2003) 1.48
Genomic approaches to antibacterial discovery. Methods Mol Biol (2004) 1.46
Nanomolar inhibitors of Staphylococcus aureus methionyl tRNA synthetase with potent antibacterial activity against gram-positive pathogens. J Med Chem (2002) 1.42
Validation of antibacterial mechanism of action using regulated antisense RNA expression in Staphylococcus aureus. FEMS Microbiol Lett (2004) 1.32
A global approach to identify novel broad-spectrum antibacterial targets among proteins of unknown function. J Mol Microbiol Biotechnol (2003) 1.31
Characterization of a novel fucose-regulated promoter (PfcsK) suitable for gene essentiality and antibacterial mode-of-action studies in Streptococcus pneumoniae. J Bacteriol (2003) 1.30
Variable sensitivity to bacterial methionyl-tRNA synthetase inhibitors reveals subpopulations of Streptococcus pneumoniae with two distinct methionyl-tRNA synthetase genes. Antimicrob Agents Chemother (2003) 1.21
Horizontal transfer of drug-resistant aminoacyl-transfer-RNA synthetases of anthrax and Gram-positive pathogens. EMBO Rep (2003) 1.20
The discovery of GSK221149A: a potent and selective oxytocin antagonist. Bioorg Med Chem Lett (2007) 1.16
The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2. Bioorg Med Chem Lett (2003) 1.16
Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin. Antimicrob Agents Chemother (2007) 1.15
Genetic characterization of Vga ABC proteins conferring reduced susceptibility to pleuromutilins in Staphylococcus aureus. Antimicrob Agents Chemother (2008) 1.15
Min-protein oscillations in Escherichia coli with spontaneous formation of two-stranded filaments in a three-dimensional stochastic reaction-diffusion model. Phys Rev E Stat Nonlin Soft Matter Phys (2006) 1.08
Definition of the heterocyclic pharmacophore of bacterial methionyl tRNA synthetase inhibitors: potent antibacterially active non-quinolone analogues. Bioorg Med Chem Lett (2004) 1.05
Characterization of Streptococcus pneumoniae TrmD, a tRNA methyltransferase essential for growth. J Bacteriol (2004) 1.01
The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing. Int Orthop (2013) 1.00
Characterization of rhodamine-123, calcein and 5(6)-carboxy-2',7'-dichlorofluorescein (CDCF) export via MRP2 (ABCC2) in MES-SA and A549 cells. Eur J Pharm Sci (2011) 0.98
Discovery and optimisation of potent, selective, ethanolamine inhibitors of bacterial phenylalanyl tRNA synthetase. Bioorg Med Chem Lett (2005) 0.94
Contextual modulation involves suppression and facilitation from the center and the surround. J Vis (2007) 0.93
Identification of antimicrobial targets using a comprehensive genomic approach. Pharmacogenomics (2004) 0.93
Spatial and temporal dependencies of cross-orientation suppression in human vision. Proc Biol Sci (2007) 0.92
Clinical and research issues regarding chronic advanced coronary artery disease: part I: Contemporary and emerging therapies. Am Heart J (2008) 0.92
In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity. Toxicology (2005) 0.92
Solid phase synthesis and SAR of small molecule agonists for the GPR40 receptor. Bioorg Med Chem Lett (2007) 0.92
Optimisation of aryl substitution leading to potent methionyl tRNA synthetase inhibitors with excellent gram-positive antibacterial activity. Bioorg Med Chem Lett (2003) 0.91
Use of a novel and highly selective oxytocin receptor antagonist to characterize uterine contractions in the rat. Am J Physiol Regul Integr Comp Physiol (2007) 0.89
Clarithromycin suppresses airway hyperresponsiveness and inflammation in mouse models of asthma. Eur J Pharmacol (2009) 0.89
Macrolide antibiotics broadly and distinctively inhibit cytokine and chemokine production by COPD sputum cells in vitro. Pharmacol Res (2011) 0.89
Azithromycin inhibits macrophage interleukin-1β production through inhibition of activator protein-1 in lipopolysaccharide-induced murine pulmonary neutrophilia. Int Immunopharmacol (2010) 0.89
Novel antibacterials: a genomics approach to drug discovery. Curr Drug Targets Infect Disord (2002) 0.88
Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity. J Med Chem (2006) 0.85
Development and biological evaluation of acyl protein thioesterase 1 (APT1) inhibitors. Angew Chem Int Ed Engl (2005) 0.85
5-aryl-pyrazolo[3,4-b]pyridazines: potent inhibitors of glycogen synthase kinase-3 (GSK-3). Bioorg Med Chem Lett (2003) 0.84
New benzylidenethiazolidinediones as antibacterial agents. Bioorg Med Chem Lett (2003) 0.84
5-aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3). Bioorg Med Chem Lett (2003) 0.84
Physicochemical profile of macrolides and their comparison with small molecules. Eur J Med Chem (2011) 0.83
Claudin-3 and Clara cell 10 kDa protein as early signals of cigarette smoke-induced epithelial injury along alveolar ducts. Toxicol Pathol (2012) 0.83
Fluorescently labeled macrolides as a tool for monitoring cellular and tissue distribution of azithromycin. Pharmacol Res (2012) 0.83
Design, synthesis, and in vitro activity of novel 2'-O-substituted 15-membered azalides. J Med Chem (2012) 0.83
Orientation masking and cross-orientation suppression (XOS): implications for estimates of filter bandwidth. J Vis (2010) 0.82
The discovery of SB-435495. A potent, orally active inhibitor of lipoprotein-associated phospholipase A(2) for evaluation in man. Bioorg Med Chem Lett (2002) 0.82
Antimalarial activity of 9a-N substituted 15-membered azalides with improved in vitro and in vivo activity over azithromycin. J Med Chem (2012) 0.82
Differences in assessment of macrolide interaction with human MDR1 (ABCB1, P-gp) using rhodamine-123 efflux, ATPase activity and cellular accumulation assays. Eur J Pharm Sci (2010) 0.81
Solid-phase synthesis of lipidated peptides. Chemistry (2005) 0.81
Intensity of macrolide anti-inflammatory activity in J774A.1 cells positively correlates with cellular accumulation and phospholipidosis. Pharmacol Res (2011) 0.81
Synthesis of macrolones with central piperazine ring in the linker and its influence on antibacterial activity. Bioorg Med Chem (2011) 0.81
Impairment of lysosomal functions by azithromycin and chloroquine contributes to anti-inflammatory phenotype. Cell Immunol (2012) 0.81
Selection for high-level telithromycin resistance in Staphylococcus aureus yields mutants resulting from an rplB-to-rplV gene conversion-like event. Antimicrob Agents Chemother (2008) 0.81
Assessment of tryptophol genotoxicity in four cell lines in vitro: a pilot study with alkaline comet assay. Arh Hig Rada Toksikol (2011) 0.80
Olive oil biophenols and women's health. Med Glas (Zenica) (2012) 0.80
Valosin containing protein (VCP) interacts with macrolide antibiotics without mediating their anti-inflammatory activities. Eur J Pharmacol (2011) 0.80
Anti-inflammatory mechanism of action of azithromycin in LPS-stimulated J774A.1 cells. Pharmacol Res (2012) 0.80
N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity. J Med Chem (2012) 0.80
Homology modeling of human Fyn kinase structure: discovery of rosmarinic acid as a new Fyn kinase inhibitor and in silico study of its possible binding modes. J Med Chem (2007) 0.79
Synthesis, activity and pharmacokinetics of novel antibacterial 15-membered ring macrolones. Eur J Med Chem (2011) 0.78
Synthesis, structure-activity relationship, and antimalarial activity of ureas and thioureas of 15-membered azalides. J Med Chem (2011) 0.78
Immunomodulatory effects of azithromycin on serum amyloid A production in lipopolysaccharide-induced endotoxemia in mice. J Antibiot (Tokyo) (2011) 0.78
The promoter of a cold-shock-like gene has pleiotropic effects on Streptomyces antibiotic biosynthesis. FEMS Microbiol Lett (2003) 0.77
Topical azithromycin and clarithromycin inhibit acute and chronic skin inflammation in sensitized mice, with apparent selectivity for Th2-mediated processes in delayed-type hypersensitivity. Inflammation (2012) 0.77
Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase. Eur J Med Chem (2009) 0.77
Remote facilitation in the Fourier domain. Vision Res (2006) 0.77
Synthesis and activity of new macrolones: conjugates between 6(7)-(2'-aminoethyl)-amino-1-cyclopropyl-3-carboxylic acid (2'-hydroxyethyl) amides and 4″-propenoyl-azithromycin. Bioorg Med Chem (2011) 0.77
Electrochemical oxidation of azithromycin and its derivatives. J Pharm Biomed Anal (2003) 0.77
Identification of impurities in acarbose by using an integrated liquid chromatography-nuclear magnetic resonance and liquid chromatography-mass spectrometry approach. J Sep Sci (2005) 0.77
Structure-property relationship for cellular accumulation of macrolones in human polymorphonuclear leukocytes (PMNs). Eur J Pharm Sci (2013) 0.77
Synthesis and activity of analogues of the isoleucyl tRNA synthetase inhibitor SB-203207. Bioorg Med Chem (2003) 0.77
Comparison of pulmonary inflammatory and antioxidant responses to intranasal live and heat-killed Streptococcus pneumoniae in mice. Inflammation (2011) 0.77
Novel ureas and thioureas of 15-membered azalides with antibacterial activity against key respiratory pathogens. Eur J Med Chem (2009) 0.76
Synthesis and biological activity of 4''-O-acyl derivatives of 14- and 15-membered macrolides linked to omega-quinolone-carboxylic unit. Bioorg Med Chem (2010) 0.76
Modeling cellular pharmacokinetics of 14- and 15-membered macrolides with physicochemical properties. J Med Chem (2011) 0.76
Novel 9a-carbamoyl- and 9a-thiocarbamoyl-3-decladinosyl-6-hydroxy and 6-methoxy derivatives of 15-membered macrolides. Bioorg Med Chem (2007) 0.76
6-Alkylquinolone-3-carboxylic acid tethered to macrolides synthesis and antimicrobial profile. Bioorg Med Chem (2010) 0.76
Could LogP be a principal determinant of biological activity in 18-crown-6 ethers? Synthesis of biologically active adamantane-substituted diaza-crowns. Eur J Med Chem (2011) 0.76
Synthesis and antibacterial activity of isomeric 15-membered azalides. J Antibiot (Tokyo) (2006) 0.76
Macrolactonolides: a novel class of anti-inflammatory compounds. Bioorg Med Chem (2012) 0.76
Novel 8a-aza-8a-homoerythromycin--4''-(3-substituted-amino)propionates with broad spectrum antibacterial activity. Bioorg Med Chem Lett (2010) 0.76
Novel desosamine-modified 14- and 15-membered macrolides without antibacterial activity. Bioorg Med Chem Lett (2012) 0.76
The anti-inflammatory activity of clarithromycin inhibits TNFalpha production and prolongs survival following lipopolysaccharide administration in mice. Int J Antimicrob Agents (2008) 0.75
Potent, orally active inhibitors of lipoprotein-associated phospholipase A(2): 1-(biphenylmethylamidoalkyl)-pyrimidones. Bioorg Med Chem Lett (2002) 0.75
Porphyrins as new endogenous anti-inflammatory agents. Eur J Pharmacol (2012) 0.75